Healthequity (HQY) Cash from Investing Activities (2013 - 2026)

Healthequity has reported Cash from Investing Activities for 14 years, with the latest figure at -$25.9 million in Q3 2026.

• On a quarterly basis, Cash from Investing Activities fell 131.8% year-over-year to -$25.9 million in Q3 2026; TTM through Jul 2026 was -$59.6 million, a 10.96% decrease from a year earlier, with the FY2026 full-year figure at -$47.1 million, up 90.67% from the prior year.
• Cash from Investing Activities was -$25.9 million for Q3 2026 at Healthequity, down from -$13.9 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$8.4 million in Q1 2026, with the low at -$471.3 million in Q1 2022.
• Average Cash from Investing Activities over 5 years is -$64.7 million, with a median of -$13.6 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities jumped 97.82% in 2023, then sank 2855.12% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$13.5 million in 2022, then dropped by 13.99% to -$15.4 million in 2023, then advanced by 16.57% to -$12.9 million in 2024, then increased by 11.54% to -$11.4 million in 2025, then slumped by 127.7% to -$25.9 million in 2026.
• The last three Cash from Investing Activities figures came in at -$25.9 million (Q3 2026), -$13.9 million (Q2 2026), and -$8.4 million (Q1 2026), per Business Quant data.